| COL3A1 |
P02461
|
collagen type III alpha 1 chain
|
|
1.00 |
0.477 |
0.808 |
49
|
395 |
| IL18 |
Q14116
|
interleukin 18
|
|
3.1E-02 |
0.365 |
0.923 |
48
|
2 |
| CYP2A6 |
P11509
|
cytochrome P450 family 2 subfamily A member 6
|
|
5.4E-09 |
0.556 |
0.731 |
44
|
3 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
42
|
277 |
| IL17A |
Q16552
|
interleukin 17A
|
|
4.3E-02 |
0.324 |
0.923 |
35
|
0 |
| KRT8 |
P05787
|
keratin 8
|
|
2.4E-08 |
0.517 |
0.654 |
35
|
7 |
| CYP2C9 |
P11712
|
cytochrome P450 family 2 subfamily C member 9
|
|
1.3E-10 |
0.506 |
0.885 |
31
|
1 |
| FGA |
P02671
|
fibrinogen alpha chain
|
|
1.2E-13 |
0.573 |
0.769 |
31
|
14 |
| IL11 |
P20809
|
interleukin 11
|
|
3.2E-04 |
0.481 |
0.808 |
29
|
1 |
| MIR10A |
|
microRNA 10a
|
|
|
0.513 |
0.846 |
29
|
0 |
| CYP2C19 |
P33261
|
cytochrome P450 family 2 subfamily C member 19
|
|
6.5E-20 |
0.467 |
0.846 |
28
|
2 |
| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
28
|
0 |
| ANXA2 |
P07355
|
annexin A2
|
|
9.8E-05 |
0.453 |
0.808 |
26
|
0 |
| MIR30A |
|
microRNA 30a
|
|
|
0.478 |
0.808 |
26
|
0 |
| H19 |
|
H19 imprinted maternally expressed transcript
|
|
|
0.494 |
0.923 |
25
|
1 |
| CFH |
P08603
|
complement factor H
|
|
0.86 |
0.441 |
0.885 |
25
|
131 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
25
|
70 |
| MIR100 |
|
microRNA 100
|
|
|
0.521 |
0.846 |
24
|
0 |
| NDUFS3 |
O75489
|
NADH:ubiquinone oxidoreductase core subunit S3
|
|
5.8E-04 |
0.581 |
0.769 |
24
|
9 |
| CCR2 |
P41597
|
C-C motif chemokine receptor 2
|
|
2.3E-02 |
0.418 |
0.846 |
24
|
2 |
| GADD45A |
P24522
|
growth arrest and DNA damage inducible alpha
|
|
4.4E-02 |
0.526 |
0.769 |
23
|
1 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
23
|
0 |
| LRAT |
O95237
|
lecithin retinol acyltransferase
|
|
2.8E-02 |
0.608 |
0.654 |
22
|
6 |
| MIR200C |
|
microRNA 200c
|
|
|
0.486 |
0.846 |
21
|
1 |